Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Common stock, par value $0.00001 per share · CUSIP: 69353Y103

Event date: 2025-03-31

Filing-level shares
3,735,396.00
Percent of class
7.19%
  • Sio Capital Management, LLC

    Shares: 3,735,396.00 · Class: 7.19%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-005584
Form type
SCHEDULE 13G
Filer
PMV Pharmaceuticals, Inc.
CIK
CIK 1699382
Filed
Apr 08, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub